Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Berlinq
    Junior Member
    • Dec 2009
    • 7

    workstation hardware

    Dear friends.
    We are going to use Roche 454 FLX and SOLID3 platforms i our lab. I need suggestions about hardware configuration for the workstation to work with sequence data. One or two CPU's? How much RAM? What about GPU? I have read that there are some progs using GPGPU with CUDA. What about atistream, as ATI cards are much more powerful? Software: Win7 or Linux?
    Thanks and greetings from Berlin
  • maubp
    Peter (Biopython etc)
    • Jul 2009
    • 1544

    #2
    Most open source tools will work on Unix (e.g. Linux, often Mac OS X), but are less likely to run on Windows.

    If you want to work with Roche 454, you will certainly need to consider running their closed source "Newbler" software - and that only runs on Linux. See:
    Pyrosequencing in picotiter plates, custom arrays for enrichment/decomplexing. (Roche)


    Whatever you are working with, you will need lots of memory. A 32bit machine limits you to 4GB of RAM, and is unsuitable but for the smallest projects (e.g. viral genomes). You will need a 64bit machine with lots of memory. How much depends on what work you'll be doing.
    Last edited by maubp; 12-08-2009, 05:11 AM. Reason: Added link

    Comment

    • Berlinq
      Junior Member
      • Dec 2009
      • 7

      #3
      Thanks for the tip. Shall it be one or two (xeon) CPUs? The main application for us will be rna-seq.

      Comment

      • maubp
        Peter (Biopython etc)
        • Jul 2009
        • 1544

        #4
        I've not worked with RNA-seq so can't offer you any useful advice there (beyond try searching the seqanswers forum).

        Comment

        • westerman
          Rick Westerman
          • Jun 2008
          • 1104

          #5
          64-bit Linux. As much memory as you can afford. 1 or 2-CPUs doesn't matter since you'll be looking at slow over-night (or multi-day) runs in any case. Unless you have specific software that will use the GPU I wouldn't bother and would instead invest the money in memory.

          Comment

          • shurjo
            Senior Member
            • Jan 2009
            • 132

            #6
            16G RAM at least

            My project consists entirely of RNA-Seq data analysis and in my experience and on our Linux x64 cluster, 16G RAM is about a minimum requirement for most jobs with even one lane of Illumina data, if you want to keep runtimes on the scale of hours instead of days.

            Comment

            • The_Roads
              Member
              • May 2009
              • 38

              #7
              I'd agree, as much ram as you can afford and i'd say multicore as well. if you are going to be using two NGS platforms it sounds like you anticipate lots of throughput. if you have four or five users waiting to get on a single workstation that is taking tens of hours to do one persons work you will end up very frustrated. i'd look at how many users you realistically expect and then decide on a hardware option. in my personal experience when NGS projects start there is way more computing done than once a project is established and folks are familiar with how to see what they are looking for in their data, thus each new user/ or project creates more work than an established one. if you have good IT support you may want to try some sort of cluster. if you are going with workstations you may find that in terms of users you have a more content lab with two smaller workstations than one huge one. we use single quad xeon workstations with 32Gb ram running CLC and a shared linux cluster for in house bioinformatics. speaking of which software is another thing to consider in your budget if you want to go commercial

              Comment

              • Berlinq
                Junior Member
                • Dec 2009
                • 7

                #8
                Thanks a lot to all for your tips. Really appreciated!

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                  by SEQadmin2


                  Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                  The systematic characterization of the human proteome has
                  ...
                  07-20-2026, 11:48 AM
                • SEQadmin2
                  Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                  by SEQadmin2



                  Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                  ...
                  07-09-2026, 11:10 AM
                • SEQadmin2
                  Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                  by SEQadmin2



                  Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                  There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                  07-08-2026, 05:17 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, 07-24-2026, 12:17 PM
                0 responses
                18 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-23-2026, 11:41 AM
                0 responses
                18 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-20-2026, 11:10 AM
                0 responses
                25 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-13-2026, 10:26 AM
                0 responses
                38 views
                0 reactions
                Last Post SEQadmin2  
                Working...